HK-listed C-Mer Eye Care hits over 4-month high on robust H1 forecast

C-Mer Medical Holdings

03/07/2019 03:21

** Shares of C-Mer Eye Care Holdings Ltd  3309.HK  surge as
much as 25% to HK$5.54, the highest since Feb. 14, after the
ophthalmic services provider forecast strong growth in first
half earnings
    ** Stock is the third biggest percentage gainer in early
trade 
    ** Co forecast its net profit for six months ended in June
to increase by more than 100% as compared with the same period a
year ago, amid an increase in revenue, and a decrease in net
loss from an eye hospital in Beijing  urn:newsml:reuters.com:*:nFWN243041
    ** It says earnings were also helped by a decrease in
foreign exchange loss arising from decreased bank deposits
denominated in Chinese yuan, and the results will be published
by end August
    ** As of Tuesday's close, the stock has fallen 11.9% so far
this year
    ** C-Mer Eye Care has underperformed the Hang Seng Commerce
& Industry Index sector  .HSNC  by 4.5 percentage points in the
past one month
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
falls 0.7%, and the benchmark index  .HSI  eases 0.3%

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)